-
Industry | |
---|---|
Sector | |
Exchange | F |
CurrencyCode | EUR |
ISIN | US55910K1088 |
Market Cap | 29M |
---|---|
Beta | 2.12 |
PE Ratio | None |
Target Price | 15.71 |
Dividend Yield | 0.0% |
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs and delivers novel monoclonal antibodies. It develops monoclonal antibodies and complement therapeutics to deliver transformative medicines for patients with rare diseases. Dianthus Therapeutics, Inc. was incorporated in 2019 and is based in Waltham, Massachusetts, with an additional office in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3MT.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025